INMB earnings: a negative outcome, -7.0%

On November 2, 2022, INmune Bio, Inc. reached its earnings. The result was a negative outcome, and the stock moved -7.0% in the window around the event. It had already run +27.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.